EWA
RCEL icon

EverSource Wealth Advisors’s Avita Medical RCEL Stock Holding History

EverSource Wealth Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96K Buy
717
+433
+152% +$1.87K ﹤0.01% 3542
2026
Q1 		$1.05K Buy
+284
New +$1.19K ﹤0.01% 3845
2025
Q4 		– Sell
-76
Closed -$388 – 4411
2025
Q3 		$388 Buy
76
+49
+181% +$256 ﹤0.01% 4012
2025
Q2 		$143 Sell
27
-129
-83% -$938 ﹤0.01% 4087
2025
Q1 		$1.27K Buy
+156
New +$1.46K ﹤0.01% 3142

Other funds holding RCEL

TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
NC
nVerses Capital Wellington, Florida $65M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

EverSource Wealth Advisors's RCEL Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Avita Medical (RCEL) stake by 152% in Q2 2026, buying an estimated $1.87K and bringing the position to 717 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

EverSource Wealth Advisors first reported a position in RCEL in Q1 2025 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • EverSource Wealth Advisors held 717 shares of Avita Medical worth $2.96K as of Q2 2026.
  • EverSource Wealth Advisors bought 433 Avita Medical shares in Q2 2026, an estimated $1.87K.
  • Avita Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3542 holding.
  • EverSource Wealth Advisors first reported a position in Avita Medical in Q1 2025 and has held it in 5 quarters since.
  • 13 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.